133 related articles for article (PubMed ID: 12454016)
1. A dominant negative mutant beta 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain.
Hill DM; Kasliwal T; Schwarz E; Hebert AM; Chen T; Gubina E; Zhang L; Kozlowski S
J Biol Chem; 2003 Feb; 278(8):5630-8. PubMed ID: 12454016
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and thermodynamics of beta 2-microglobulin binding to the alpha 3 domain of major histocompatibility complex class I heavy chain.
Hebert AM; Strohmaier J; Whitman MC; Chen T; Gubina E; Hill DM; Lewis MS; Kozlowski S
Biochemistry; 2001 May; 40(17):5233-42. PubMed ID: 11318646
[TBL] [Abstract][Full Text] [Related]
3. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
Lee L; McHugh L; Ribaudo RK; Kozlowski S; Margulies DH; Mage MG
Eur J Immunol; 1994 Nov; 24(11):2633-9. PubMed ID: 7957555
[TBL] [Abstract][Full Text] [Related]
4. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin.
Smith JD; Solheim JC; Carreno BM; Hansen TH
Mol Immunol; 1995 May; 32(7):531-40. PubMed ID: 7783756
[TBL] [Abstract][Full Text] [Related]
5. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of beta 2-microglobulin.
Shields MJ; Assefi N; Hodgson W; Kim EJ; Ribaudo RK
J Immunol; 1998 Mar; 160(5):2297-307. PubMed ID: 9498770
[TBL] [Abstract][Full Text] [Related]
7. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
Apasov S; Sitkovsky M
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
[TBL] [Abstract][Full Text] [Related]
8. A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity.
Mage MG; Lee L; Ribaudo RK; Corr M; Kozlowski S; McHugh L; Margulies DH
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10658-62. PubMed ID: 1438262
[TBL] [Abstract][Full Text] [Related]
9. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
Glas R; Ohlén C; Höglund P; Kärre K
J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
[TBL] [Abstract][Full Text] [Related]
11. The role of beta 2-microglobulin in peptide binding by class I molecules.
Vitiello A; Potter TA; Sherman LA
Science; 1990 Dec; 250(4986):1423-6. PubMed ID: 2124002
[TBL] [Abstract][Full Text] [Related]
12. Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin.
Boyd LF; Kozlowski S; Margulies DH
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2242-6. PubMed ID: 1549590
[TBL] [Abstract][Full Text] [Related]
13. Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences.
Tysoe-Calnon VA; Grundy JE; Perkins SJ
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):359-69. PubMed ID: 1859364
[TBL] [Abstract][Full Text] [Related]
14. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
Uger RA; Barber BH
J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
[TBL] [Abstract][Full Text] [Related]
15. Different features of the MHC class I heterodimer have evolved at different rates. Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues.
Kaufman J; Andersen R; Avila D; Engberg J; Lambris J; Salomonsen J; Welinder K; Skjødt K
J Immunol; 1992 Mar; 148(5):1532-46. PubMed ID: 1538136
[TBL] [Abstract][Full Text] [Related]
16. Exogenous beta 2-microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules.
Kane KP; Sherman LA; Mescher MF
Eur J Immunol; 1991 Sep; 21(9):2289-92. PubMed ID: 1889467
[TBL] [Abstract][Full Text] [Related]
17. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
Restifo NP; Marincola FM; Kawakami Y; Taubenberger J; Yannelli JR; Rosenberg SA
J Natl Cancer Inst; 1996 Jan; 88(2):100-8. PubMed ID: 8537970
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer.
Bouvier M; Wiley DC
Nat Struct Biol; 1998 May; 5(5):377-84. PubMed ID: 9587000
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide.
Ribaudo RK; Margulies DH
J Immunol; 1995 Oct; 155(7):3481-93. PubMed ID: 7561043
[TBL] [Abstract][Full Text] [Related]
20. An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide.
Sugita M; Brenner MB
J Exp Med; 1994 Dec; 180(6):2163-71. PubMed ID: 7964491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
